{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:27:15Z","timestamp":1794554835625,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,11,2]]},"DOI":"10.1038\/s41416-025-03145-8","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:13:24Z","timestamp":1756221204000},"page":"1122-1136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Aberrant PJA2-CHRM3 signaling creates a therapeutic vulnerability in gastric tumor"],"prefix":"10.1038","volume":"133","author":[{"given":"Lingmeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0349-3262","authenticated-orcid":false,"given":"Jingyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongli","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2645-0953","authenticated-orcid":false,"given":"Xuefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-3698","authenticated-orcid":false,"given":"Liyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"3145_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41568-019-0237-2","volume":"20","author":"AH Zahalka","year":"2020","unstructured":"Zahalka AH, Frenette PS. Nerves in cancer. Nat Rev Cancer. 2020;20:143\u201357.","journal-title":"Nat Rev Cancer"},{"key":"3145_CR2","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200358","volume":"11","author":"SS Senga","year":"2021","unstructured":"Senga SS, Grose RP. Hallmarks of cancer-the new testament. Open Biol. 2021;11:200358.","journal-title":"Open Biol"},{"key":"3145_CR3","first-page":"250ra115","volume":"6","author":"CM Zhao","year":"2014","unstructured":"Zhao CM, Hayakawa Y, Kodama Y, Muthupalani S, Westphalen CB, Andersen GT, et al. Denervation suppresses gastric tumorigenesis. Sci Transl Med. 2014;6:250ra115.","journal-title":"Sci Transl Med"},{"key":"3145_CR4","doi-asserted-by":"crossref","DOI":"10.1126\/science.1236361","volume":"341","author":"C Magnon","year":"2013","unstructured":"Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, et al. Autonomic nerve development contributes to prostate cancer progression. Science. 2013;341:1236361.","journal-title":"Science"},{"key":"3145_CR5","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1158\/1078-0432.CCR-08-1164","volume":"14","author":"GE Ayala","year":"2008","unstructured":"Ayala GE, Dai H, Powell M, Li R, Ding Y, Wheeler TM, et al. Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res. 2008;14:7593\u2013603.","journal-title":"Clin Cancer Res"},{"key":"3145_CR6","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1002\/cncr.26117","volume":"117","author":"D Albo","year":"2011","unstructured":"Albo D, Akay CL, Marshall CL, Wilks JA, Verstovsek G, Liu H, et al. Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes. Cancer. 2011;117:4834\u201345.","journal-title":"Cancer"},{"key":"3145_CR7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrgastro.2015.166","volume":"12","author":"IE Demir","year":"2015","unstructured":"Demir IE, Friess H, Ceyhan GO. Neural plasticity in pancreatitis and pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2015;12:649\u201359.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3145_CR8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1158\/0008-5472.CAN-15-2790","volume":"78","author":"C Bressy","year":"2018","unstructured":"Bressy C, Lac S, Nigri J, Leca J, Roques J, Lavaut MN, et al. LIF drives neural remodeling in pancreatic cancer and offers a new candidate biomarker. Cancer Res. 2018;78:909\u201321.","journal-title":"Cancer Res"},{"key":"3145_CR9","volume":"6","author":"H You","year":"2020","unstructured":"You H, Shang W, Min X, Weinreb J, Li Q, Leapman M, et al. Sight and switch off: nerve density visualization for interventions targeting nerves in prostate cancer. Sci Adv. 2020;6:eaax6040.","journal-title":"Sci Adv"},{"key":"3145_CR10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","volume":"41","author":"D Hanahan","year":"2023","unstructured":"Hanahan D, Monje M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell. 2023;41:573\u201380.","journal-title":"Cancer Cell"},{"key":"3145_CR11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1572-0241.2000.02074.x","volume":"95","author":"M Cassaro","year":"2000","unstructured":"Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000;95:1431\u20138.","journal-title":"Am J Gastroenterol"},{"key":"3145_CR12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41575-022-00669-9","volume":"19","author":"N Vaes","year":"2022","unstructured":"Vaes N, Idris M, Boesmans W, Alves MM, Melotte V. Nerves in gastrointestinal cancer: from mechanism to modulations. Nat Rev Gastroenterol Hepatol. 2022;19:768\u201384.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3145_CR13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0016-5085(00)70191-0","volume":"118","author":"MS Bedine","year":"2000","unstructured":"Bedine MS. Textbook of gastroenterology. Gastroenterology. 2000;118:984\u20135.","journal-title":"Gastroenterology"},{"key":"3145_CR14","doi-asserted-by":"crossref","first-page":"G521","DOI":"10.1152\/ajpgi.00105.2004","volume":"289","author":"G Xie","year":"2005","unstructured":"Xie G, Drachenberg C, Yamada M, Wess J, Raufman JP. Cholinergic agonist-induced pepsinogen secretion from murine gastric chief cells is mediated by M1 and M3 muscarinic receptors. Am J Physiol Gastrointest Liver Physiol. 2005;289:G521\u2013G9.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3145_CR15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188313","volume":"1873","author":"K Wang","year":"2020","unstructured":"Wang K, Zhao XH, Liu J, Zhang R, Li JP. Nervous system and gastric cancer. Biochim Biophys Acta Rev Cancer. 2020;1873:188313.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3145_CR16","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1572-0241.2007.01161.x","volume":"102","author":"S Bahmanyar","year":"2007","unstructured":"Bahmanyar S, Ye W, Dickman PW, Nyr\u00e9n O. Long-term risk of gastric cancer by subsite in operated and unoperated patients hospitalized for peptic ulcer. Am J Gastroenterol. 2007;102:1185\u201391.","journal-title":"Am J Gastroenterol"},{"key":"3145_CR17","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1158\/1078-0432.CCR-14-3163","volume":"21","author":"N Wang","year":"2015","unstructured":"Wang N, Yao M, Xu J, Quan Y, Zhang K, Yang R, et al. Autocrine activation of CHRM3 promotes prostate cancer growth and castration resistance via CaM\/CaMKK-mediated phosphorylation of Akt. Clin Cancer Res. 2015;21:4676\u201385.","journal-title":"Clin Cancer Res"},{"key":"3145_CR18","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1158\/0008-5472.CAN-07-6810","volume":"68","author":"J-P Raufman","year":"2008","unstructured":"Raufman J-P, Samimi R, Shah N, Khurana S, Shant J, Drachenberg C, et al. Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia. Cancer Res. 2008;68:3573\u20138.","journal-title":"Cancer Res"},{"key":"3145_CR19","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","volume":"23","author":"HHN Yan","year":"2018","unstructured":"Yan HHN, Siu HC, Law S, Ho SL, Yue SSK, Tsui WY, et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell. 2018;23:882\u201397.","journal-title":"Cell Stem Cell"},{"key":"3145_CR20","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1158\/2159-8290.CD-20-1109","volume":"11","author":"YH Lo","year":"2021","unstructured":"Lo YH, Kolahi KS, Du Y, Chang CY, Krokhotin A, Nair A, et al. A CRISPR\/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals essential and non-essential modes of oncogenic transformation. Cancer Discov. 2021;11:1562\u201381.","journal-title":"Cancer Discov"},{"key":"3145_CR21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1541-7786.MCR-21-0441","volume":"20","author":"H Li","year":"2022","unstructured":"Li H, Fu X, Zhao J, Li C, Li L, Xia P, et al. EXOC4 promotes diffuse-type gastric cancer metastasis via activating FAK signal. Mol Cancer Res. 2022;20:1021\u201334.","journal-title":"Mol Cancer Res"},{"key":"3145_CR22","volume":"9","author":"L Huang","year":"2018","unstructured":"Huang L, Zhao J, Chen H, Wan L, Inuzuka H, Guo J, et al. SCFFBW7-mediated degradation of Brg1 suppresses gastric cancer metastasis. Nat Commun. 2018;9:3569.","journal-title":"Nat Commun"},{"key":"3145_CR23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/jgh.13818","volume":"33","author":"J Zhao","year":"2018","unstructured":"Zhao J, Li H, Min L, Han X, Shu P, Yang Y, et al. High expression of tumor necrosis factor receptor-associated factor 2 promotes tumor metastasis and is associated with unfavorable prognosis in gastric cancer. J Gastroenterol Hepatol. 2018;33:431\u201342.","journal-title":"J Gastroenterol Hepatol"},{"key":"3145_CR24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"AJ Bass","year":"2014","unstructured":"Bass AJ, Thorsson V, Shmulevich I, Reynolds SM, Miller M, Bernard B, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139.","journal-title":"Nature"},{"key":"3145_CR25","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","volume":"19","author":"C Gravalos","year":"2008","unstructured":"Gravalos C, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol. 2008;19:1523\u20139.","journal-title":"Ann Oncol"},{"key":"3145_CR26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687\u201397.","journal-title":"Lancet"},{"key":"3145_CR27","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/CIRCULATIONAHA.117.027288","volume":"135","author":"EM Antman","year":"2017","unstructured":"Antman EM. Evaluating the cardiovascular safety of nonsteroidal anti-inflammatory drugs. Circulation. 2017;135:2062\u201372.","journal-title":"Circulation"},{"key":"3145_CR28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2016.11.005","volume":"31","author":"Y Hayakawa","year":"2017","unstructured":"Hayakawa Y, Sakitani K, Konishi M, Asfaha S, Niikura R, Tomita H, et al. Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling. Cancer Cell. 2017;31:21\u201334.","journal-title":"Cancer Cell"},{"key":"3145_CR29","volume":"7","author":"L Wang","year":"2018","unstructured":"Wang L, Xu J, Xia Y, Yin K, Li Z, Li B, et al. Muscarinic acetylcholine receptor 3 mediates vagus nerve-induced gastric cancer. Oncogenesis. 2018;7:88.","journal-title":"Oncogenesis"},{"key":"3145_CR30","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.juro.2006.09.079","volume":"177","author":"T Oki","year":"2007","unstructured":"Oki T, Kageyama A, Takagi Y, Uchida S, Yamada S. Comparative evaluation of central muscarinic receptor binding activity by oxybutynin, tolterodine and darifenacin used to treat overactive bladder. J Urol. 2007;177:766\u201370.","journal-title":"J Urol"},{"key":"3145_CR31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-5347(05)00017-0","volume":"175","author":"S Maruyama","year":"2006","unstructured":"Maruyama S, Oki T, Otsuka A, Shinbo H, Ozono S, Kageyama S, et al. Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder. J Urol. 2006;175:365\u20139.","journal-title":"J Urol"},{"key":"3145_CR32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/CAD.0000000000000432","volume":"28","author":"A Mannan Baig","year":"2017","unstructured":"Mannan Baig A, Khan NA, Effendi V, Rana Z, Ahmad HR, Abbas F. Differential receptor dependencies: expression and significance of muscarinic M1 receptors in the biology of prostate cancer. Anticancer Drugs. 2017;28:75\u201387.","journal-title":"Anticancer Drugs"},{"key":"3145_CR33","doi-asserted-by":"crossref","first-page":"C1123","DOI":"10.1152\/ajpcell.00070.2019","volume":"318","author":"M Gong","year":"2020","unstructured":"Gong M, Ye S, Li WX, Zhang J, Liu Y, Zhu J, et al. Regulatory function of praja ring finger ubiquitin ligase 2 mediated by the P2rx3\/P2rx7 axis in mouse hippocampal neuronal cells. Am J Physiol Cell Physiol. 2020;318:C1123\u2013C35.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3145_CR34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrc3120","volume":"11","author":"S Lipkowitz","year":"2011","unstructured":"Lipkowitz S, Weissman AM. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer. 2011;11:629\u201343.","journal-title":"Nat Rev Cancer"},{"key":"3145_CR35","volume":"19","author":"L Zheng","year":"2021","unstructured":"Zheng L, Xu H, Di Y, Chen L, Liu J, Kang L, et al. ELK4 promotes the development of gastric cancer by inducing M2 polarization of macrophages through regulation of the KDM5A-PJA2-KSR1 axis. J Transl Med. 2021;19:342.","journal-title":"J Transl Med"},{"key":"3145_CR36","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.18632\/aging.202356","volume":"13","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhu L, Xing Y, Zhang Z. Praja2 suppresses the growth of gastric cancer by ubiquitylation of KSR1 and inhibiting MEK-ERK signal pathways. Aging. 2021;13:3886\u201397.","journal-title":"Aging"},{"key":"3145_CR37","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.109","volume":"7","author":"L Rinaldi","year":"2016","unstructured":"Rinaldi L, Delle Donne R, Sepe M, Porpora M, Garbi C, Chiuso F, et al. praja2 regulates KSR1 stability and mitogenic signaling. Cell Death Dis. 2016;7:e2230.","journal-title":"Cell Death Dis"},{"key":"3145_CR38","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms2791","volume":"4","author":"L Lignitto","year":"2013","unstructured":"Lignitto L, Arcella A, Sepe M, Rinaldi L, Delle Donne R, Gallo A, et al. Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth. Nat Commun. 2013;4:1822.","journal-title":"Nat Commun"},{"key":"3145_CR39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/ncb2209","volume":"13","author":"L Lignitto","year":"2011","unstructured":"Lignitto L, Carlucci A, Sepe M, Stefan E, Cuomo O, Nistic\u00f2 R, et al. Control of PKA stability and signalling by the RING ligase praja2. Nat Cell Biol. 2011;13:412\u201322.","journal-title":"Nat Cell Biol"},{"key":"3145_CR40","doi-asserted-by":"crossref","DOI":"10.1186\/1750-2187-3-20","volume":"3","author":"VA Mosser","year":"2008","unstructured":"Mosser VA, Jones KT, Hoffman KM, McCarty NA, Jackson DA. Differential role of beta-arrestin ubiquitination in agonist-promoted down-regulation of M1 vs M2 muscarinic acetylcholine receptors. J Mol Signal. 2008;3:20.","journal-title":"J Mol Signal"},{"key":"3145_CR41","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s13277-015-4011-0","volume":"37","author":"L Wang","year":"2016","unstructured":"Wang L, Zhi X, Zhang Q, Wei S, Li Z, Zhou J, et al. Muscarinic receptor M3 mediates cell proliferation induced by acetylcholine and contributes to apoptosis in gastric cancer. Tumour Biol. 2016;37:2105\u201317.","journal-title":"Tumour Biol"},{"key":"3145_CR42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.stem.2022.04.006","volume":"29","author":"S Ding","year":"2022","unstructured":"Ding S, Hsu C, Wang Z, Natesh NR, Millen R, Negrete M, et al. Patient-derived micro-organospheres enable clinical precision oncology. Cell Stem Cell. 2022;29:905\u201317.","journal-title":"Cell Stem Cell"},{"key":"3145_CR43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, Corbo V, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160:324\u201338.","journal-title":"Cell"},{"key":"3145_CR44","volume":"10","author":"M Kim","year":"2019","unstructured":"Kim M, Mun H, Sung CO, Cho EJ, Jeon HJ, Chun SM, et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat Commun. 2019;10:3991.","journal-title":"Nat Commun"},{"key":"3145_CR45","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.4049\/jimmunol.1003507","volume":"187","author":"AL Tatler","year":"2011","unstructured":"Tatler AL, John AE, Jolly L, Habgood A, Porte J, Brightling C, et al. Integrin \u03b1v\u03b25-mediated TGF-\u03b2 activation by airway smooth muscle cells in asthma. J Immunol. 2011;187:6094\u2013107.","journal-title":"J Immunol"},{"key":"3145_CR46","doi-asserted-by":"crossref","first-page":"L589","DOI":"10.1152\/ajplung.00400.2011","volume":"303","author":"TA Oenema","year":"2012","unstructured":"Oenema TA, Smit M, Smedinga L, Rack\u00e9 K, Halayko AJ, Meurs H, et al. Muscarinic receptor stimulation augments TGF-\u03b21-induced contractile protein expression by airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2012;303:L589\u2013L97.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3145_CR47","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1172\/JCI27183","volume":"116","author":"RG Jenkins","year":"2006","unstructured":"Jenkins RG. Ligation of protease-activated receptor 1 enhances \u03b1v\u03b26 integrin-dependent TGF\u03b2-activation and promotes acute lung injury. J Clin Invest. 2006;116:1606\u201314.","journal-title":"J Clin Invest"},{"key":"3145_CR48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12931-016-0344-5","volume":"17","author":"JJ Lu","year":"2016","unstructured":"Lu JJ, Xu GN, Yu P, Song Y, Wang XL, Zhu L, et al. The activation of M3 mAChR in airway epithelial cells promotes IL-8 and TGF-\u03b21 secretion and airway smooth muscle cell migration. Respir Res. 2016;17:25.","journal-title":"Respir Res"},{"key":"3145_CR49","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1111\/febs.16297","volume":"289","author":"R Mohamed","year":"2021","unstructured":"Mohamed R, Shajimoon A, Afroz R, Gabr M, Thomas WG, Little PJ, et al. Akt acts as a switch for GPCR transactivation of the TGF\u2010\u03b2 receptor type 1. FEBS J. 2021;289:2642\u201356.","journal-title":"FEBS J"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03145-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T14:24:07Z","timestamp":1760624647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03145-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11,2]]}},"alternative-id":["3145"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03145-8","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal studies were approved by the Institutional Animal Care and Use Committee (IACUC) of Shanghai Jiao Tong University (Approval Number: 20221035). This study, involving human participants, was approved by the Ethics Committee of Fudan University (Approval Number: B2021-449R) and was carried out in accordance with the ethical standards stipulated in the 1964 Declaration of Helsinki. Each patient receives written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}